Financial consolidation, cultivation regulation, and strengthening of events mark the sector's prospects for the next year

Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence

For Fritz Eduardo Kasbaum the scientific ecosystem is ready to expand, but still depends on changes in national regulation

Badger G® variety promises to boost the pharmaceutical sector and facilitate monitoring with red leaves and high CBG content

While the federal government delays the delivery of rules for cultivation, states are advancing with their own legislation and building a framework that could anticipate the direction of national regulation

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers

Court analyzes whether the substance is a medicine or a health product, which directly impacts the funding and access to cannabidiol by the SUS

Extract from the company Endogen expands the portfolio of options for medicinal treatments and already has sanitary authorization for commercialization

Without defined rules, veterinarians face legal uncertainty and animals still have limited access to medicinal cannabis treatment

Unveiling the secrets and benefits of the cannabis subspecies in relation to cotton

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.